Form D · Biotechnology

Cellanome, Inc.

Foster City, CA · CIK 0001886462

Offering snapshot reported Jun 22, 2026 · SEC filing

Reported sold
$75.9M
Offering amount: $75.9M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 23, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 22, 2026Initial$75,930,476No comparison22SEC filing
Jan 29, 2024Initial$149,999,997No comparison20SEC filing
Mar 21, 2023Amendment$40,664,711$10,707,605vs Aug 5, 202211SEC filing
Aug 5, 2022Initial$29,957,106No comparison10SEC filing
Dec 6, 2021Initial$20,999,996No comparison2SEC filing
Oct 5, 2021Initial$2,049,990No comparison17SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-588010
Series C Preferred Stock

Source: Form D, filed Jun 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ali Agah Executive
Rowan Chapman Director
Jay Flatley Director
Mehdi Khodadad Executive
Tarun Khurana Executive
Sue Mc Grath Executive
Kazutaka Ohno Executive
Omead Ostadan Director, Executive
Sandesh Patnam Director
Mostafa Ronaghi Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
500 Lincoln Centre Dr., 3rd Floor
Foster City, CA, 94404